Dr. Thomas Marron, MD PhD
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
24 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
FGFR2 positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
RECIST 1.1
Affiliated Hospitals
Clinical Trials Thomas Marron, MD PhD is currently running
SIM1811-03
for Cutaneous T-Cell Lymphoma
This is a first in human, open-label, dose escalation and expansion Phase 1 study of SIM1811-03 in adult patients with advanced solid tumors and cutaneous T-cell lymphoma. SIM1811-03 is a first-in-class IgG1-based humanized anti-tumor necrosis factor type 2 receptor (TNFR2) monoclonal antibody for the treatment of malignant tumors.
Recruiting1 award Phase 1
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting1 award Phase 2
More about Thomas Marron, MD PhD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Thomas Marron, MD PhD has experience with
- Pembrolizumab
- BMS-986253
- Nivolumab
- Dupilumab
- Cemiplimab
- Botensilimab
Breakdown of trials Thomas Marron, MD PhD has run
Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Marron, MD PhD specialize in?
Thomas Marron, MD PhD focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thomas Marron, MD PhD currently recruiting for clinical trials?
Yes, Thomas Marron, MD PhD is currently recruiting for 7 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Thomas Marron, MD PhD has studied deeply?
Yes, Thomas Marron, MD PhD has studied treatments such as Pembrolizumab, BMS-986253, Nivolumab.
What is the best way to schedule an appointment with Thomas Marron, MD PhD?
Apply for one of the trials that Thomas Marron, MD PhD is conducting.
What is the office address of Thomas Marron, MD PhD?
The office of Thomas Marron, MD PhD is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.